Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Douglas, C. Goh, K. Winfield, S. Stick, P. Sly, S. Brennan (Perth, Australia). The diagnostic value of pseudomonas aeruginosa serology as markers of early respiratory infection in young children with cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 2661

Member's Comments

No comment yet.

Related content which might interest you: Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Pseudomonas aeruginosa infections Source: Respipedia Article Year: 2018 Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis Source: Eur Respir J 2009; 33: 305-311 Year: 2009 Diagnostic value of serological tests against Pseudomonas aeruginosa in cystic fibrosis patients Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 The efficacy of early eradication therapy in prevention of chronic pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 486s Year: 2006 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 DNA fingerprinting of pseudomonas aeruginosa in cystic fibrosis patients: risk assessment of cross-infection in a CF centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections Source: Eur Respir J 2012; 40: 227-238 Year: 2012 MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis Source: ERJ Open Res 2016 Year: 2016 Early re-colonization with pseudomonas aeruginosa (PA) after treatment: a possible risk factor for development of chronic infection in cystic fibrosis (CF) patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Pseudomonas aeruginosa in patients with cystic fibrosis - a comparison of early eradication and conventional therapy Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Viral infections trigger exacerbations of cystic fibrosis in adults and children Source: Eur Respir J 2012; 40: 510-512 Year: 2012 Audit on the MRSA infection in adults with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis? Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis Source: Eur Respir J 2004; 24 : 631-637 Year: 2004 Achromobacter (A.) xylosoxidans in cystic fibrosis: prevalence and clinical relevance Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 The identification of bacterial strains in specimens of adult cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004